Home News Artificial Intelligence and Medical Imaging: Noémie Moreau Defends Her Thesis at the Baclesse Center

Artificial Intelligence and Medical Imaging: Noémie Moreau Defends Her Dissertation at the Baclesse Center

Nov. 20, 2026

Search
Artificial Intelligence and Medical Imaging: Noémie Moreau Defends Her Dissertation at the Baclesse Center
Support us Support us Healthcare professionals Pro Directory Directory Appointment Appointment Access to the Center Access

On November 12, 2026, Noémie Moreau defended her dissertation in the lecture hall at the Baclesse Center. Her dissertation focused on the use of artificial intelligence and medical imaging to better characterize brain tumors and predict the effectiveness of treatments.

Titled “Artificial Intelligence and Medical Imaging for the Characterization of Brain Tumors and the Prediction of Treatment Efficacy,” this dissertation falls within a rapidly growing field of research at the intersection of artificial intelligence and personalized medicine.

Better Predicting the Progression of Brain Tumors Using AI

Noémie Moreau’s research has focused in particular on glioblastoma, the most common and most aggressive primary malignant brain tumor in adults. Despite treatments combining surgery, radiation therapy, and chemotherapy, the median survival time for patients is approximately 15 months. Furthermore, responses to treatment vary greatly from one patient to another.

In this context, his work has focused on developing artificial intelligence models capable of predicting patient survival based on MRI images taken before radiation therapy, combined with various clinical data.

A database open to the scientific community

This research also contributed to the publication of the CFB-GBM database, which compiles MRI images and radiation therapy data from 264 patients with glioblastoma.

Available to the public on the international platform The Cancer Imaging Archive (TCIA), this database serves as a resource for the scientific community and promotes the development of new research in medical imaging.

New Research Directions

Future prospects include the integration of radiation therapy dose maps to study tumor control and toxicity risks, the extension of the models to other treatments (proton therapy and carbon therapy), and the development of multicenter studies using federated learning.

Supervised by Dr. Aurélien Corroyer-Dulmont, this dissertation was conducted within the AImaging group at the ISTCT unit (UMR 6030) and the Baclesse Center. It received funding in equal parts from the Normandy Region and the Baclesse Center.

The Baclesse Center extends its warmest congratulations to Noémie Moreau on this important milestone in her scientific career and extends its heartfelt thanks to her thesis advisor and all members of the committee for their participation in this thesis defense.

Jury Members:

  • Dr. Francesca Galassi, University of Rennes – Rapporteur
  • Dr. Aurélien Corroyer-Dulmont, ISTCT, Baclesse Center – Thesis Advisor
  • Dr. Charlotte Robert, Paris-Saclay University – Rapporteur
  • Prof. Juliette Thariat, University of Caen Normandy – Examiner
  • Dr. Samuel Valable, ISTCT, University of Caen Normandy – Examiner and Chair of the Examination Committee
  • Prof. John Aldo Lee, University of Leuven – Examiner (remotely)

Related publications:

  • Moreau et al., Frontiers in Radiology, 2026. DOI: 10.3389/fradi.2026.1963539
  • Moreau et al., 2025. DOI: 10.7937/V9PN-2F72
  • Leclercq et al., Melba, 2026. DOI: 10.59275/j.melba.2026-dd48
Publication date :
Date of last update :
Extravasation in Nuclear Medicine: The Role of 3D Dosimetry Contents
Generic filters